Longeveron Inc. (LGVN)
NASDAQ (CM) NASDAQ (CM) Primary 
LGVN Stock Alert: Longeveron Pops 18% on FDA Fast-Track Designation
Longeveron (NASDAQ: LGVN ) stock is rocketing higher on Wednesday after the clinical-stage biotechnology company received fast-track designation for its mild Alzheimer's Disease treatment. This has the Food and Drug Administration (FDA) granting this designation to Lomecel-B.
Longeveron stock opened 100% up on Wednesday: explore why
Longeveron Inc (NASDAQ: LGVN) soared 100% on Wednesday after its Lomecel-B received RMAT designation from the Food & Drug Administration. Lomecel-B is the company's investigational treatment for Alzheimer's disease.
Why Is Longeveron (LGVN) Stock Up 53% Today?
Longeveron (NASDAQ: LGVN ) stock is rocketing higher on Wednesday after the clinical-stage biotechnology company announced a new designation from the Food and Drug Administration (FDA). This has the FDA granting Longeveron's Lomecel-B the Regenerative Medicine Advanced Therapy (RMAT) designation.
Why has Longeveron stock tripled in two days?
Longeveron Inc (NASDAQ: LGVN) rallied another 50% on Thursday as investors continued to celebrate the positive update of its Lomecel-B study. Why is it significant for Longeveron stock?
Why Is Longeveron (LGVN) Stock Up 46% Today?
Longeveron (NASDAQ: LGVN ) stock continues to rally on Thursday as investors celebrate positive trial news from the clinical-stage biotechnology company. The big news that boosted shares of LGVN stock higher was investigator data from a Phase 2 trial of Lomocel-B.
Why Is Longeveron (LGVN) Stock Up 120% Today?
The clinical-stage biotech market is as vast as it is complicated. Companies operating in this space are wide-ranging in the illnesses they look to treat.
Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript
Longeveron Inc. (NASDAQ:LGVN ) Q1 2024 Earnings Conference Call May 14, 2024 5:00 PM ET Company Participants Derek Cole - IR, Advisory Solutions Wa'el Hashad - CEO Nataliya Agafonova - Chief Medical Officer Lisa Locklear - CFO Joshua Hare - Co-Founder, Chief Science Officer and Chairman of the Board Conference Call Participants Ram Selvaraju - H.C. Wainwright Operator Good day, ladies and gentlemen, and welcome to Longeveron 2024 First Quarter Financial Results Earnings Call.
